IRCT20130408012941N2 IRCT 2022-02-08 Mashhad University of Medical Sciences Curcumin effect in patients with type 2 diabetes mellitus and co-existent dislipidemia Effects of supplementation with curcumin on serum lipid level in patients with type 2 diabetes mellitus and co-existence dislipidemia: A randomized placebo-controlled trial 2022-02-20 anticipated 80 Complete https://irct.ir/trial/60925 interventional Randomization: Randomized, Blinding: Triple blinded, Placebo: Used, Assignment: Parallel, Purpose: Treatment, Randomization description: Using block randomization method, the random number sequences will be generated through https://www.Randomization.com. The random number sequences are determined for the required sample size (n=40 in each group). Following, after patients enter the study based on the inclusion criteria, according to the list of the random number sequences generated, individuals are allocated to one of the intervention and placebo groups, and this continues until the number of patients in each group is completed, Blinding description: Using drugs with similar shape, smelling and color. 3 patients with type 2 diabetes mellitus and co-existence dislipidemia. Intervention 1: Intervention group: Patients with type 2 diabetes mellitus and co-existence dislipidemia will recieve curcumin 500 mg and piperidin 5mg with standard care for 12 weeks. Intervention 2: Control group: Patients with type 2 diabetes mellitus and co-existence dislipidemia will recieve placebo with standard care for 12 weeks. No - There is not a plan to make this available Justification or reason for not sharing IPD is Principal investigators are committed to presenting all the achivements of the project based on the Mashhad University of Medical Sciences protocol.